You are here: Home » Markets » News
Business Standard

Indices end at record closing high; Nifty settles Oct expiry above 10,300

All that happened in the market today

SI Reporter  |  New Delhi 

markets, stocks, sensex, nifty, bse, nse
Photo: Shutterstock

Benchmark indices rose in the last leg of the trade to ended the day at fresh highs at October expiry with Nifty50 surpassing 10,350-mark. The broader ended at fresh high too.

S&P settled at new high of 33,147, up 104 points for the day. Nifty50, on the other hand, also achieved new milestone, ending at fresh closing high of 10,334, up 39 points.

The market remained flat for most of the day, faltering a bit after having touched record highs in the previous session as investors booked profits in recent outperformers such as State Bank of India.

Asian stocks stalled on Thursday, weighed as Wall Street shares pulled back from record highs, while the euro stretched gains ahead of a European Central Bank policy meeting at which it could take a major step away from accommodative policy.

The sentiment was dampened after a senior North Korean official said that  the recent warning from North Korea’s foreign minister of a possible atmospheric nuclear test over the Pacific Ocean should be taken literally.

Indices end at record closing high; Nifty settles Oct expiry above 10,300

Market rundown by Mr. Anand James, Chief Market Strategist of Geojit Financial Services    "Profit booking in some PSBs and derivatives’ expiry kept markets guessing even as global peers remained on the backfoot ahead of a bunch of central bank meetings. However, sectoral cues kept markets buoyant with firm metal prices leading metal and mining companies higher while small and midcap segments outperformed the broad market indices on anticipation of better outcomes from the MSMEs meeting with the GST council scheduled on Sunday."

Indices end at record closing high; Nifty settles Oct expiry above 10,300

Sectoral trend Source: NSE

Indices end at record closing high; Nifty settles Oct expiry above 10,300

Top Sectoral Gainer: Nifty Metal index Source: NSE

Indices end at record closing high; Nifty settles Oct expiry above 10,300

Nifty PSU Bank index snap's Wednesday's 30% rally Source: NSE

Indices end at record closing high; Nifty settles Oct expiry above 10,300

Top Sensex gainers and losers  Source: BSE

Indices end at record closing high; Nifty settles Oct expiry above 10,300

Broader Markets Broader markets ended at fresh highs too. the BSE Midcap and BSE Smallcap indeces were trading higher by 0.5% and 0.6% respectively

Indices end at record closing high; Nifty settles Oct expiry above 10,300

Markets at close Benchmark indices rose in the last leg of the trade to ended the day at fresh highs at October expiry with Nifty50 surpassing 10,350-mark. S&P BSE Sensex settled at new high of 33,147, up 104 points for the day. Nifty50, on the other hand, also achieved new milestone, ending at fresh closing high of 10,334, up 39 points.

Indices end at record closing high; Nifty settles Oct expiry above 10,300

Buzzing Stock Saksoft rose 6.83% to Rs 223 on BSE after the company's promoter SAK Industries acquired 0.94% stake in the company.

Indices end at record closing high; Nifty settles Oct expiry above 10,300

Markets at fresh highs Sensex rose as much as 154 points to hit the record high of 33,196 , surpassing its previous milestone of 33,117 hit on Oct 25 while Nifty gained as much as 40 points to hit 10,355, surpassing the last high of 10,340 hit on Oct 25.

Indices end at record closing high; Nifty settles Oct expiry above 10,300

Markets at 3pm Index Current Pt. Change % Change   S&P BSE SENSEX 33,070.37 +27.87 +0.08   S&P BSE SENSEX 50 10,699.04 +16.70 +0.16   S&P BSE SENSEX Next 50 35,796.11 +318.46 +0.90   S&P BSE 100 10,741.97 +29.73 +0.28   S&P BSE MidCap 16,336.54 +87.18 +0.54 (Source: BSE)

Indices end at record closing high; Nifty settles Oct expiry above 10,300

Centrum on GSK Pharma   We maintain our Sell rating on GlaxoSmithKline Pharma (GSK) and revise our target price to Rs1,525 (earlier Rs1,390) based on 24x March’19E EPS of Rs63.4. GSK’s Q2FY18 results exceeded our and consensus estimates. GSK revenue grew by 5%, EBIDTA margin improved 540bps to 23.0% and net profit grew 27% YoY.    GSK’s pharma segment grew by 6.3% during the quarter. That said, the company has a strong presence in the vaccines segment and is likely to derive growth from the same. Key risks to our assumptions include faster-than-expected growth in the domestic market and higher growth of its flagship brands. We recommend a switch to other pharma companies, Abbott India or Sanofi India, due to GSK’s rich valuations.

First Published: Thu, October 26 2017. 15:30 IST
RECOMMENDED FOR YOU

Indices end at record closing high; Nifty settles Oct expiry above 10,300

All that happened in the market today

Benchmark indices rose in the last leg of the trade to ended the day at fresh highs at October expiry with Nifty50 surpassing 10,350-mark. The broader ended at fresh high too.

S&P settled at new high of 33,147, up 104 points for the day. Nifty50, on the other hand, also achieved new milestone, ending at fresh closing high of 10,334, up 39 points.

The market remained flat for most of the day, faltering a bit after having touched record highs in the previous session as investors booked profits in recent outperformers such as State Bank of India.

Asian stocks stalled on Thursday, weighed as Wall Street shares pulled back from record highs, while the euro stretched gains ahead of a European Central Bank policy meeting at which it could take a major step away from accommodative policy.

The sentiment was dampened after a senior North Korean official said that  the recent warning from North Korea’s foreign minister of a possible atmospheric nuclear test over the Pacific Ocean should be taken literally.

image
Business Standard
177 22